Please login or register to print this page.

The British Journal
of Cardiology

This website is intended for healthcare professionals only

H.E.A.R.T UK: hyperlipidaemia and the challenges ahead

November 2003    Volume 10, Issue 6   Br J Cardiol 2003;10:416-7

Authors:
Julie Foxton, Anthony Wierzbicki, John Reckless

The merits of reducing cholesterol to help prevent coronary
heart disease (CHD) were questioned 10 years ago.
There were great debates about the utility of reducing
low-density lipoprotein cholesterol (LDL-C) and it is now clear,
following the publication of at least eight different clinical drug
trials, that reducing cholesterol with statin drugs helps to
reduce total mortality, cardiovascular mortality and morbidity
and interventional procedures.

In the near future, you will need to be a registered user to view full articles

Already a member? Login now

Register Now

Close

back to top

Comments

There are currently no comments for this article - leave a comment

You must be logged in to post a comment.
Not yet a member? Register now for free.

back to top

Close

You are not logged in

You need to be a member to print this page.
Sign up for free membership, or log in.

Find out more about our membership benefits

Close

You are not logged in

You need to be a member to download PDF's.
Sign up for free membership, or log in.

Find out more about our membership benefits